cagrilintide retatrutide combination trial Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 cagrilintide semaglutide trial We – www cagrilintide blend with retatrutide -

This elevated risk reinforced the post-marketing signals regulators were already seeing

GLP-1 is of relevance to appetite and weight maintenance because it has actions on the gastrointestinal tract as well as the direct regulation of appetite

Key points for patients: GLP-1 therapies help clear skin and reduce painful, swollen joints Obesity makes PsA harder to treat, so weight loss from GLP-1 meds helps In studies, patients on GLP-1s had fewer flares, less pain, and felt better overall

Talk to Your Doctor About Medication Adjustments: If youre experiencing persistent nausea, which can lead to enamel decay, dont suffer through it

Dual and triple GLP-1 agonists are next-generation therapies that activate multiple receptors to enhance metabolic effects

A 2024 study published in the Journal of Clinical Investigation found that semaglutide reduced alcohol intake in people with AUD by approximately 30-40%